BackNovo Nordisk Overview

Novo Nordisk Current Assets

Track Novo Nordisk's current assets ($180B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$177.32B
↑ 1.68% YoYΔ $2.92B vs prior year quarter

Peer average

Loading

Novo Nordisk Current Assets History

Loading

Novo Nordisk vs. peers: Current Assets Comparison

Loading

Novo Nordisk Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Novo Nordisk (NVO) FAQ

As of the most recent data (March 2026), NVO shows a current assets of $180B. That compares with $170B in the prior-year period — up 1.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVO's current assets is now $180B (was $170B) — a 1.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Nordisk is outperforming or lagging.

Tracking NVO's current assets over time shows whether Novo Nordisk is scaling, shrinking, or reshaping that part of the business. The current reading is $180B That compares with $170B in the prior-year period — up 1.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Novo Nordisk's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $180B) with ownership activity and broader fundamentals.

Novo Nordisk's current assets is $180B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.